$country= Comparative statistics by cancer registry - SurvCan

Comparative statistics by cancer registry

Registry: Comparative statistics by cancer site

Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site

(Shanghai, China, 1992-1995 cases followed-up until 2000)

Click on cancer site (ICD-10 code) for comparison
SiteICD-10TotalAbsolute survival %Relative survival %ASRS% at 5-years
1-year3-year5-year1-year3-year5-yearall ages0-74 years
C00Lip4283.371.459.586.880.973.978.884.1
C01-02Tongue20672.359.754.874.364.061.564.166.9
C03-06Oral cavity28575.160.653.477.767.063.468.570.9
C07-08Salivary gland18987.874.065.989.778.773.471.073.7
C09Tonsil5972.456.252.674.660.960.461.062.1
C11Nasopharynx106078.960.851.980.263.556.052.957.6
C12-13Hypopharynx3751.429.724.353.433.229.731.231.0
C15Oesophagus298834.715.913.136.317.916.018.020.6
C16Stomach1173545.828.724.847.631.729.330.436.0
C17Small intestine22948.028.424.049.530.827.627.932.1
C18Colon478266.348.643.068.453.450.648.254.0
C19-20Rectum328470.548.640.872.753.247.744.151.0
C21Anus9369.948.139.172.553.947.545.849.9
C22Liver695418.48.97.519.09.68.68.99.8
C23-24Gall bladder138324.114.412.725.016.015.219.221.0
C25Pancreas224216.27.36.516.98.17.88.59.5
C30-31Nose/Sinuses20067.948.743.669.952.749.848.552.4
C32Larynx62474.856.749.977.863.560.661.767.2
C33-34Lung1410434.115.112.435.416.915.015.618.0
C37-38Other thoracic organs40348.635.432.449.937.836.033.241.4
C40-41Bone52342.829.627.344.231.630.127.834.0
C43Melanoma skin11074.455.144.177.060.551.555.461.7
C44Other skin47284.574.569.588.084.285.886.085.9
C47+C49Connective tissue48273.061.656.774.565.262.458.362.9
C50Breast518490.879.273.192.082.678.777.879.4
C51Vulva5468.551.948.171.257.557.755.956.5
C52Vagina4571.148.841.873.052.947.942.849.5
C53Cervix54877.057.852.479.062.560.161.663.5
C54Corpus uteri73590.382.879.791.686.385.782.386.9
C55Uterus unspecified14549.031.029.750.633.432.737.649.5
C56Ovary108766.448.442.767.350.345.643.547.9
C57Other female genital3591.367.747.192.971.251.655.650.1
C60Penis4987.873.567.391.783.583.384.290.7
C61Prostate63968.844.036.973.153.050.848.854.2
C62Testis11382.377.074.383.279.077.580.181.7
C64Kidney74363.151.546.565.055.853.351.260.3
C65Renal pelvis6774.655.250.777.261.661.670.771.2
C66Ureter6885.354.448.487.859.356.165.673.0
C67Urinary bladder175071.956.851.175.465.064.362.974.5
C68Other urinary organs2684.646.242.388.953.054.062.164.3
C69Eye4090.077.569.891.681.475.878.679.1
C70-72Brain & nervous system190654.242.439.855.344.342.848.851.1
C73Thyroid86890.587.285.691.589.689.889.791.2
C74Adrenal gland12380.578.073.981.580.477.771.369.5
C75Other endocrine33085.780.977.486.683.181.270.878.0
C81Hodgkin lymphoma9980.767.462.381.869.966.075.177.6
C82-85+C96Non-Hodgkin lymphoma127156.339.235.157.741.939.243.345.6
C90Multiple myeloma23049.128.319.550.630.622.325.128.1
C91Lymphoid leukaemia33852.732.227.853.533.830.228.830.4
C92-94Myeloid leukaemia60551.731.425.452.632.727.127.230.0
C95Leukaemia unspecified37726.314.611.126.915.512.313.314.6


Graphs:


Other tables available for this registry:
- Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Shanghai, China, 1992-1995 cases followed-up until 2000)
- Table2a: Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Shanghai, China, 1992-1995 cases followed-up until 2000)
- Table3: Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Shanghai, China, 1992-1995 cases followed-up until 2000)
- Table4: Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Shanghai, China, 1992-1995 cases followed-up until 2000)
- Table5: Comparison of 5-year absolute and relative survival of cases diagnosed between 1988-1991 and 1992-1995 (Shanghai, China)




Registry chapter:


Consult the chapter in Cancer survival in developping countries (Volume II)